Risk Evaluation and Mitigation Strategies (REMS)

First Page		Document Content
Pharmaceutical industry Pharmaceutical sciences Food law Clinical research Drug safety New Drug Application Risk management Package insert Federal Food Drug and Cosmetic Act Food and Drug Administration Medicine Health		Risk Evaluation and Mitigation Strategies (REMS) Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 165,46 KB Share Document on Facebook

	NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato DocID: 1uASt - View Document
	Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DocID: 1tBOU - View Document
	RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson DocID: 1roDS - View Document
	Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration DocID: 1rmMY - View Document
	Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff DocID: 1r7Xt - View Document